Global Anti-Aging Medicine Market Insights, Forecast to 2028

Anti-aging medicine is the branch of medicine which aims to reduce the chance of developing aging-related arteriosclerosis and other aging-related diseases, including cancer, by intervening in the biological process of aging, and thereby contributing to the extension of a healthy life span.
Market Analysis and Insights: Global Anti-Aging Medicine Market
Due to the COVID-19 pandemic, the global Anti-Aging Medicine market size is estimated to be worth US$ 9962.3 million in 2022 and is forecast to a readjusted size of US$ 19310 million by 2028 with a CAGR of 11.7% during the review period. Fully considering the economic change by this health crisis, Dermal Fillers accounting for % of the Anti-Aging Medicine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
China Anti-Aging Medicine market size is valued at US$ million in 2021, while the US and Europe Anti-Aging Medicine are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Anti-Aging Medicine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Anti-Aging Medicine include Allergan, Galderma, LG Life Science, Merz Pharma, Medytox, Hugel, IMEIK, Haohai Bio and Daewoong Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Anti-Aging Medicine Scope and Segment
Anti-Aging Medicine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Anti-Aging Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
Dermal Fillers
Botulinum Toxin
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
E-commerce
Drug Stores

By Company
Allergan
Galderma
LG Life Science
Merz Pharma
Medytox
Hugel
IMEIK
Haohai Bio
Daewoong Pharmaceutical
Bloomage
Suneva Medical
SciVision Biotech

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE